LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

First Ever COVID-19 Portable Sweat Test Device Delivers Results in 30 Seconds

By LabMedica International staff writers
Posted on 13 Sep 2021
Print article
Image: The Portable Sweat Test Device for COVID-19 (Photo courtesy of Chulalongkorn University)
Image: The Portable Sweat Test Device for COVID-19 (Photo courtesy of Chulalongkorn University)
A first-ever COVID-19 portable sweat test device can yield instant results and could support proactive screening in the community.

Researchers at Chulalongkorn University (Bangkok, Thailand) have successfully developed, for the first time, a quick and easy-to-use portable sweat test device for COVID-19 to detect specific scents in sweat caused by bacteria. Sample collection only takes 15 minutes per person, and the results can be obtained in 30 seconds. The sweat test is now being used in community screening. The test is based on the success of the “COVID-19 Sniffer Dogs” project that uses sweat sniffer dogs to detect asymptomatic COVID-19 cases in the community.

People’s sweat may have more than 100 unique scents — be it from the powder, roll-on deodorant, or the bacteria that feed on sweat or skin secretions, then excrete the substances that are mixed with sweat. The portable sweat test device was developed from a commercially available portable chemistry analyzer which is generally used to measure chemicals that are toxic to the environment. To adapt it to detect COVID-19, the researchers installed a specific filter to detect the virus. The advantage of this method is that it can be adapted to detect mutated variants of the virus or other microorganisms. Field tests of the device on 2,000 people alongside the PCR (Polymerase Chain Reaction) testing found the results to be on a par – with 95% sensitivity and 98% specificity.

“For those infected with COVID-19, the bacteria react abnormally to the virus and produce some distinct odors unique to COVID-19 infection,” explained Asst. Prof. Dr. Chadin Kulsing, Department of Chemistry, Faculty of Science, Chulalongkorn University. “The test kit consists of a glass vial and a cotton swab which screeners will receive one each. The screeners would place the cotton swab under the armpit of the person receiving the test and leave it for about 15 minutes. After that, the cotton swab is put in the glass vile, which is then sterilized with UV rays. The technician then draws an appropriate amount of the sample using a suction hose, and pressurizes it into the analyzer to check the results.”

Related Links:
Chulalongkorn University

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.